NRT Smoking Cessation Aids in the US

NRT Smoking Cessation Aids in the US

  • October 2020 •
  • 28 pages •
  • Report ID: 149238 •
  • Format: PDF
Although the fear of compromising lung health was widespread during the early stages of the COVID-19 outbreak in the US, there was little distinguishable impact on the NRT smoking cessation aids products. Studies have shown that there is no concrete evidence that smokers are at greater risk of contracting COVID-19, although some studies have shown that there may be a link to the severity of the disease, if contracted.

NRT Smoking Cessation Aids in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.

Product coverage:
NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.

Data coverage:
market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the NRT Smoking Cessation Aids market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

We are very sorry, but an error occurred.
Please contact if the problem remains.